MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
4.89
-0.01 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
4.98
1.90%
After-hours: Aug 15, 2025, 07:55 PM EDT

MEI Pharma Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
65.3M 48.82M 40.7M 25.54M
Cost of Revenue
383K 1.81M 1.24M 1.41M
Gross Profit
64.91M 47M 39.46M 24.13M
Operating Income
14.54M -36.76M -75.48M -69.69M
Interest Income
3.28M 3.35M 284K 510K
Pretax Income
17.78M -31.84M -54.45M -50.57M
Net Income
17.78M -31.84M -54.45M -41.31M
Selling & General & Admin
23.3M 33.13M 30.54M 24.41M
Research & Development
16.56M 52.45M 85.64M 69.4M
Other Expenses
10.9M -22K -6K 486K
Operating Expenses
50.76M 85.58M 116.18M 93.81M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
50.76M 85.58M 116.18M 95.22M
Income Tax Expense
n/a n/a 284K 8K
Shares Outstanding (Basic)
6.66M 6.66M 6.22M 5.63M
Shares Outstanding (Diluted)
6.66M 6.66M 6.26M 5.72M
EPS (Basic)
2.67 -4.78 -8.75 -7.4
EPS (Diluted)
2.67 -4.78 -9.99 -12
EBITDA
26.38M -36.76M -75.16M -60.14M
EBIT
25.44M -36.76M -75.48M -60.42M
Depreciation & Amortization
383K 1.81M 1.24M 285K